tirzepatide heart failure trial Another "Positive" that Falls Short SUMMIT: Tirzepatide a 'Huge Win'
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
SUMMIT: Tirzepatide a 'Huge Win' for HFpEF Patients With Obesity Tirzepatide for Heart Failure in Patients with Obesity NEJM Reaching the SUMMIT? Benefits and potential risks associated with the use of tirzepatide in heart failure with preserved ejection fraction ScienceDirect Treatment with #tirzepatide in the SUMMIT trial led to a lower risk of death from cardiovascular causes or worsening heart failure and improved health status in patients with #HFpEF and obesity. https: t.co O9iU9a1Xgw Tirzepatide cardiovascular event risk assessment: a pre specified meta analysis Nature Medicine How the weight loss drug tirzepatide is also helping heart failure patients
Store: clickpoint.com.au · Domain: clickpoint.com.au












![Skye Bioscience, Inc. (SKYE) Securities Class Action Lawsuit Update [December 10, 2025]](https://dropinblog.net/cdn-cgi/image/fit=scale-down,width=700/34260815/files/1765476602820.webp)











